Arkos Global Advisors’s Biohaven BHVN Stock Holding History

Arkos Global Advisors’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,500	Closed	-$30K	–	130
2026 Q1	$30K	Buy	+3,500	New	+$38.3K	﹤0.01%	191

Other funds holding BHVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arkos Global Advisors's BHVN Position: Q2 2026 in Review

Arkos Global Advisors sold out of Biohaven (BHVN) in Q2 2026, closing a stake of 3,500 shares — an estimated $30K sold.

Arkos Global Advisors first reported a position in BHVN in Q1 2026 and held it in 1 quarter. The position peaked at $30K in Q1 2026. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

Arkos Global Advisors reported no remaining Biohaven position as of Q2 2026 after selling out during the quarter.
Arkos Global Advisors sold 3,500 Biohaven shares in Q2 2026, an estimated $30K.
Arkos Global Advisors first reported a position in Biohaven in Q1 2026 and held it in 1 quarter.
Arkos Global Advisors's Biohaven position peaked at $30K in Q1 2026.
292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Arkos Global Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.